P1101, phase 1, healthy volunteers
Showing 1 - 25 of >10,000
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Healthy Subjects Trial in Melbourne (AP301)
Not yet recruiting
- Healthy Subjects
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Oct 20, 2023
Hepatocellular Carcinoma Trial in Taipei city (P1101 (Ropeginterferon alfa-2b), Nivolumab)
Recruiting
- Hepatocellular Carcinoma
- P1101 (Ropeginterferon alfa-2b)
- Nivolumab
-
Taipei city, TaiwanNational Taiwan university Hospital
Jan 25, 2022
Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)
Completed
- Nonalcoholic Steatohepatitis
- HUYPS-1 one tablet
- HUYPS-1 nine tablets
-
Taipei, TaiwanTri-Service General Hospital
Aug 1, 2023
Healthy Trial in Adelaide (XH-S003 (A), Placebo (B))
Not yet recruiting
- Healthy
- XH-S003 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 21, 2023
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Adult Volunteers Trial in Beijing (VSA001 injection, Placebo)
Not yet recruiting
- Healthy Adult Volunteers
- VSA001 injection
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Feb 23, 2023
Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))
Completed
- Safety
- +2 more
- RHN-001 (one tablet 750mg)
- RHN-001 (750mg * 2 Tablets)
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023
Healthy Volunteers Trial in Secaucus (NRS-033, Placebo)
Not yet recruiting
- Healthy Volunteers
- NRS-033
- Placebo
-
Secaucus, New JerseyFrontage Clinical Research Center
Feb 10, 2023
Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)
Recruiting
- Adrenocortical Carcinoma
- 68Ga-R8760 injection at pre-defined dose levels
- 68GA-R8760 injection
-
Ann Arbor, MichiganUniversity of Michigan Nuclear Medicine
Aug 11, 2023
Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)
Recruiting
- Healthy Volunteers
- Zoliflodacin Patheon
-
Berlin, GermanyParexel Early Phase Clinical Unit
Nov 22, 2022
Healthy Volunteers Trial in Antwerpen (P03277 0.1 mmol/kg, Moxifloxacin 400mg, NaCl 0.9%)
Completed
- Healthy Volunteers
- P03277 0.1 mmol/kg
- +3 more
-
Antwerpen, BelgiumClinical Pharmacology unit, SGS-Life Science Service
Mar 22, 2022
Healthy Trial in Seoul (ID120040002, Compound-X, Placebo comparator)
Recruiting
- Healthy
- ID120040002
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 21, 2022
Healthy Volunteer Trial in Los Angeles (IRL201104, Placebo)
Recruiting
- Healthy Volunteer
- IRL201104
- Placebo
-
Los Angeles, CaliforniaRevolo Phase I site
Jun 19, 2023
Amyotrophic Lateral Sclerosis Trial in Melbourne (SPG302, Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- SPG302
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Melbourne
May 22, 2023
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)
Completed
- Healthy
- CT-L01 12.5/1,000 mg
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)
Active, not recruiting
- Alcohol Use Disorder
- DCR-AUD
- Placebo
-
Glendale, CaliforniaParexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023
Healthy Adult Volunteers Trial in Adelaide (DR-0201, Placebo)
Not yet recruiting
- Healthy Adult Volunteers
- DR-0201
- Placebo
-
Adelaide, South Australia, AustraliaDren Investigational Site
Aug 18, 2023